Animal models of invasive aspergillosis for drug discovery

Area of Science:

• Medical Mycology
• Infectious Diseases
• Preclinical Research

Background:

• Invasive aspergillosis is a serious threat to immunocompromised individuals.
• Limited antifungal drug options and increasing drug resistance complicate treatment.
• High-quality animal studies are essential for novel antifungal drug discovery.

Purpose of the Study:

• To review key aspects of designing in vivo models for invasive aspergillosis.
• To guide researchers in tailoring preclinical antifungal evaluation protocols.
• To facilitate the identification of novel antifungal agents.

Main Methods:

• Discussion of critical elements in animal model design for invasive aspergillosis.
• Consideration of species, immune modulation, and inoculation routes.
• Evaluation of Aspergillus strains, treatment strategies, and efficacy assessment.

Main Results:

• Provides a comprehensive overview of factors influencing invasive aspergillosis animal models.
• Highlights the importance of specific protocol design for different preclinical studies.
• Enables informed selection and adaptation of models for antifungal research.

Conclusions:

• Optimized animal models are vital for advancing antifungal drug development.
• Standardized and well-designed models will accelerate the discovery of effective treatments.
• This review serves as a guide for robust preclinical evaluation of antifungal therapies.